Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis

Lupus

Volumn 20, Issue 13, 2011, Pages 1404-1410

  Hung, W T ^a   Chen, Y M ^a,b   Lan, J L ^a,b,c   Chen, H H ^a,b   Chen, Y H ^a,b   Chen, D Y ^a,b,c,d   Hsieh, C W ^a,b,d   Wen, M C ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

activity index; antinucleosome antibody; chronicity; index; lupus nephritis; renal biopsy

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; NUCLEOSOME ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; COMPLEMENT C3; COMPLEMENT C4; FEMALE; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NUCLEOSOMES; PROTEINURIA;

EID: 81555207580     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311417033     Document Type: Article

References (32)

1. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM. 1999 ; 92: 211-218 (Pubitemid 29184885)
2. Schwartz MM, Lan SP, Bonsib SM, Gephardt GN, Sharma HM. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis. 1989 ; 13: 273-283 (Pubitemid 19109078)
3. Leaker B, Fairley KF, Dowling J. Kincaid-Smith P. Lupus nephritis: Clinical and pathological correlation. QJM. 1987 ; 62: 163-179 (Pubitemid 17042880)
4. Moroni G, Pasquali S, Quaglini S, et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis. 1999 ; 34: 530-539 (Pubitemid 29413627)
5. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 2001 ; 59: 2156-2163 (Pubitemid 32467607)
6. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000 ; 35: 904-914 (Pubitemid 30238204)
7. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: Diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006 ; 33: 1563-1569 (Pubitemid 44168828)
8. Burstein DM, Schwartz MM, Korbet SM. Percutaneous renal biopsy with the use of real-time ultrasound. Am J Nephrol. 1991 ; 11: 195-200
9. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupud erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Medicine (Baltimore). 1978 ; 57: 371-410 (Pubitemid 8398526)
10. Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR. Role of apoptosis in autoimmunity. Apoptosis. 2000 ; 5: 443-449 (Pubitemid 32162628)
11. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: Getting rid of the corpses. Mol Cell. 2004 ; 14: 277-287 (Pubitemid 38607340)
12. Muller S, Dieker J, Tincani A, Meroni PL. Pathogenic anti-nucleosome antibodies. Lupus. 2008 ; 17: 431-436 (Pubitemid 351798722)
13. Düzgün N, Sahin M, Genç Y, Tutkak H. Antinucleosome antibodies and systemic lupus erythematosus. Ann N Y Acad Sci. 2007 ; 1109: 421-428 (Pubitemid 47511385)
14. Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol. 2000 ; 12: 369-373
15. Amoura Z, Koutouzov S, Chabre H, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum. 2000 ; 43: 76-84 (Pubitemid 30368215)
16. Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford). 2004 ; 43: 220-224 (Pubitemid 38219679)
17. Campos LM, Kiss MH, Scheinberg MA, Mangueira CL, Silva CA. Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus. Lupus. 2006 ; 15: 496-500 (Pubitemid 44289546)
18. Benucci M, Gobbi FL, Del Rosso A, Cesaretti S, Niccoli L, Cantini F. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol. 2003 ; 32: 42-45 (Pubitemid 36169518)
19. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 2000 ; 43: 2307-2315
20. Carvalho JF, Viana VST, Borba EF, et al. High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis. Clin Rheumatol. 2008 ; 27: 1417-1421
21. Duzgun N, Sahin M, Genc Y, Tutkak H. Antinucleosome antibodies and systemic lupus erythematosus. Annals of the New York Academy of Sciences. 2007 ; 1109: 421-428 (Pubitemid 47511385)
22. Saisoong S, Eiam-Ong S, Hanvivatvong O. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clin Exp Rheumatol. 2006 ; 24: 51-58
23. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
24. Marks SD, Pilkington C, Woo P, Dillon MJ. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford). 2004 ; 43: 1186-1189 (Pubitemid 39232827)
25. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004 ; 65: 521-530 (Pubitemid 38130646)
26. Cairns AP, McMillan SA, Crockard AD, et al. Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis. 2003 ; 62: 272-273 (Pubitemid 36238099)
27. Ghirardelloa A, Doriaa A, Zampieria S, et al. Journal of Autoimmunity. 2004 ; 22: 235-240
28. Suleiman S, Kamaliah D, Nadeem A, Naing NN, Maraina CHC. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus. Int J Rheum Dis. 2009 ; 12: 100-106
29. Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ. Anti-dsDNA: Choice of assay in relation to clinical value. Rheumatol Int. 1991 ; 11: 101-107
30. Cervera R, Vinas O. Ramos-Casals M, et al. Anti-chromatin antibodies in systemic lupus erythematosus: A useful marker for lupus nephropathy. Ann Rheum Dis. 2003 ; 62: 431-434 (Pubitemid 36469734)
31. Bigler C, Lopez-Trascasa M, Potlukova E, et al. Antinucleosome antibodies as a marker of active proliferative lupus nephritis. Am J Kidney Dis. 2008 ; 51: 624-629 (Pubitemid 351400832)
32. Grootscholten C, Dieker JW. McGrath FD, et al. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/ methylprednisolone. Ann Rheum Dis. 2007 ; 66: 693-696 (Pubitemid 46707143)